Frontlight ResearchEarly access
Type 2 diabetes trials in Switzerland
11 of 16 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleEASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Where
- Basel, Lausanne, Lucerne, Lugano, Sankt Gallen, Zurich
- Age
- 18 years and over
- People
- 11,800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00 - No phaseNot yet taking people in SwitzerlandUse and Acceptability of an AI-Assisted Health Application for Individuals Living With a Chronic Condition
- Where
- Geneva
- Age
- 18 years and over
- People
- 1,600
- Run by
- Fondation Net-Care.ch
See details and how to joinNCT07916753 - Phase 2Not yet taking people in SwitzerlandOsilodrostat for Glycemic Control in Mild Autonomous Cortisol Secretion (MACS) With Difficult-To-Control Type 2 Diabetes - A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study
- Where
- Basel
- Age
- 18 years to 74 years
- People
- 44
- Run by
- Beckey Trinh
See details and how to joinNCT07922148 - Phase 3CompletedA Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
- Where
- Geneva
- Age
- 18 years to 65 years
- People
- 57 worldwide
- Run by
- Vertex Pharmaceuticals Incorporated
See details and how to joinNCT04786262 · EU 2024-513929-23-00 - No phaseNot yet taking people in SwitzerlandClosed-loop in Adults With Type 2 Diabetes
- Where
- Bern
- Age
- 18 years and over
- People
- 224 worldwide
- Run by
- University of Cambridge
See details and how to joinNCT06579404 - Phase 2Taking peopleDapansutrile in Diabetes and Diabetes-Related Complications - Dapan-Dia
- Where
- Basel, Olten
- Age
- 18 years to 75 years
- People
- 300 worldwide
- Run by
- Marc Donath
See details and how to joinNCT06047262 · EU 2024-511828-14-00 - No phaseNot yet taking people in SwitzerlandEffects of Fecal Microbiota Transplantation in Patients With Type 2 Diabetes and Coronary Artery Disease (CAD-Microbiome) - A Pilot Study
- Where
- Zurich
- Age
- 18 years to 75 years
- People
- 30
- Run by
- University of Zurich
See details and how to joinNCT07421947 - No phaseTaking peopleClosed-Loop Impact on Chronic Kidney Disease in Type 2 Diabetes
- Where
- Lausanne
- Age
- 18 years and over
- People
- 76
- Run by
- Heba Al-Alwan
See details and how to joinNCT06925217 - No phaseNot yet taking people in SwitzerlandSupporting Patients Starting New Medicines: Evaluating the myCare Start Service in Switzerland
- Where
- Geneva
- Age
- 18 years and over
- People
- 1,600
- Run by
- University of Geneva, Switzerland
See details and how to joinNCT07036471 - No phaseNot yet taking people in SwitzerlandMonitoring of Brain Metabolites Using Proton and Deuterium MR Techniques
- Where
- Bern
- Age
- 18 years to 130 years
- People
- 140
- Run by
- Insel Gruppe AG, University Hospital Bern
See details and how to joinNCT06705010 - No phaseTaking peopleBicycle Exercise and Lifestyle Intervention in Newly Diagnosed Diabetes
- Where
- Basel, Delémont, Olten
- Age
- 18 years and over
- People
- 62
- Run by
- University Hospital, Basel, Switzerland
See details and how to joinNCT03827382